InvestorsHub Logo
Followers 4
Posts 401
Boards Moderated 0
Alias Born 03/02/2006

Re: None

Monday, 03/10/2014 6:29:03 PM

Monday, March 10, 2014 6:29:03 PM

Post# of 346182
Germany approves DCVax-L for GBM while in the middle of Phase III trial.

"DCVax-L is among an emerging new crop of drugs that coax the body's immune system to track down and kill cancer cells. More specifically, it harnesses dendritic cells, or master cells of the immune system that give marching orders to its soldiers, including t-cells and b-cells, which make antibodies."

http://www.reuters.com/article/2014/03/10/us-northwestbiotherapeutics-cancer-idUSBREA290KA20140310

Co. website: http://nwbio.com/about-dcvax/

Another immunotherapy compatible with Bavi?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News